Prevalence of Prescribed Attention-Deficit Hyperactivity Disorder Medications and Diagnosis among Canadian Preschoolers and School-Age Children: 1994–2007

Objective: To describe trends in the prevalence of prescribed attention-deficit hyperactivity disorder (ADHD) medication by Canadian preschoolers and school-age children and to compare these with trends in the prevalence of the ADHD diagnosis between 1994 and 2007. Methods: Subjects participated in the National Longitudinal Survey on Children and Youth, a Canadian prospective survey collecting data biennially. Three cross-sectional samples of nonreferred children, aged 3 to 9 years and representative of Canadian children for 1994–1995 (n = 12 595), 2000–2001 (n = 13 904), and 2006–2007 (n = 14 655), were selected for the analyses. Information on prescribed medications and ADHD diagnosis was reported by each child's parents. Prevalence was estimated at each cycle, taking the child's age and sex into account. Results: The estimated prevalence of prescribed medications and ADHD diagnosis in Canada was generally low (less than 3%), but higher for boys (less than 4%) and school-age children (less than 5%). Preschoolers' prevalence of both prescribed medications and ADHD diagnosis stayed stable between 1994 and 2007 (1% or less), while that of school-age children increased nearly 2-fold. Boys' prevalence was higher than that of girls, but girls show the steepest increase over time, up to 2.1-fold. The association between prescribed medications and ADHD diagnosis has strengthened during the 2000s: a greater number of medications were used for children with ADHD (from 43% in 2000 to 59% in 2007) while off-label use of prescribed medications decreased among school-age children. Conclusions: The upward trend in the prevalence of prescribed ADHD medications and ADHD diagnosis currently observed in contemporary societies is also occurring in Canada, except with preschoolers.

[1]  C. Lalonde,et al.  Prescription of methylphenidate to children and youth, 1990-1996. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[2]  D. Mattison,et al.  Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. , 2007, Journal of child and adolescent psychopharmacology.

[3]  S. Faraone,et al.  Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects. , 2005, The American journal of psychiatry.

[4]  M. Brancaccio.  Educational hyperactivity: The historical emergence of a concept , 2000 .

[5]  D. Sclar,et al.  National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995 , 1999, Clinical pediatrics.

[6]  P. Levine,et al.  Treatment with stimulants among youths in a large California health plan. , 2005, Journal of child and adolescent psychopharmacology.

[7]  F. Glascoe,et al.  Increasing identification of psychosocial problems. , 2001, Pediatrics.

[8]  Christine B Phillips.  Medicine Goes to School: Teachers as Sickness Brokers for ADHD , 2006, PLoS medicine.

[9]  P. Conrad,et al.  Deviance and Medicalization: From Badness to Sickness , 1992 .

[10]  Sheik Hosenbocus,et al.  A review of long-acting medications for ADHD in Canada. , 2009, Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent.

[11]  E. Parens,et al.  Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies , 2009, Child and Adolescent Psychiatry and Mental Health.

[12]  D. Sclar,et al.  Is Attention Deficit Hyperactivity Disorder Increasing Among Girls in the US? , 2002, CNS drugs.

[13]  M. Gleason,et al.  Psychopharmacology and preschoolers: a critical review of current conditions. , 2009, Child and adolescent psychiatric clinics of North America.

[14]  P. Conrad.  Identifying hyperactive children: The medicalization of deviant behavior , 1976 .

[15]  M. Wilson,et al.  DSM-III and the transformation of American psychiatry: a history. , 1993, The American journal of psychiatry.

[16]  W. Burke,et al.  The Role of Stimulants in the Treatment of Preschool Children with Attention-Deficit Hyperactivity Disorder , 2004, CNS drugs.

[17]  J. Oosterlaan,et al.  How Common are Symptoms of ADHD in Typically Developing Preschoolers? a Study on Prevalence Rates and Prenatal/Demographic Risk Factors , 2007, Cortex.

[18]  C. Malacrida.  Medicalization, Ambivalence and Social Control: Mothers’ Descriptions of Educators and ADD/ADHD , 2004, Health.

[19]  A. Philalithis,et al.  Variations in prevalence of attention deficit hyperactivity disorder worldwide , 2006, European Journal of Pediatrics.

[20]  L. Weyandt,et al.  School‐based Intervention for Children with Attention Deficit Hyperactivity Disorder: Effects on academic, social, and behavioural functioning , 2006 .

[21]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[22]  T. To,et al.  Correlates of Methylphenidate Use in Canadian Children: A Cross-Sectional Study , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[23]  Susan Waterman.  Identifying Hyperactive Children , 1978 .

[24]  G. Glaeske,et al.  A three-country comparison of psychotropic medication prevalence in youth , 2008, Child and adolescent psychiatry and mental health.

[25]  J. Hugtenburg,et al.  Increased psychotropic drug consumption by children in the Netherlands during 1995–2001 is caused by increased use of methylphenidate by boys , 2004, European Journal of Clinical Pharmacology.

[26]  F. Lynch,et al.  Trends in the prescribing of psychotropic medications to preschoolers. , 2000, JAMA.

[27]  L. Greenhill,et al.  Child and Adolescent Psychiatry and Mental Health Off-label Psychopharmacologic Prescribing for Children: History Supports Close Clinical Monitoring , 2008 .

[28]  Sengwee Toh,et al.  Datapoints: trends in ADHD and stimulant use among children, 1993-2003. , 2006, Psychiatric services.

[29]  L. Greenhill,et al.  Attention-deficit hyperactivity disorder in preschool children , 2008, Archives of Disease in Childhood.

[30]  C.Keith Conners.  Identifying hyperactive children: The medicalization of deviant behavior , 1980 .

[31]  G. Norquist,et al.  Recent trends in stimulant medication use among U.S. children. , 2006, The American journal of psychiatry.

[32]  M. Campbell,et al.  Why are girls with ADHD invisible , 2006 .

[33]  E. Goodman,et al.  Trends in the use of psychotropic medications among adolescents, 1994 to 2001. , 2006, Psychiatric services.

[34]  R. Tremblay,et al.  Prevalence of methylphenidate use and change over a two-year period: a nationwide study of 2- to 11-year-old Canadian children. , 2002, The Journal of pediatrics.

[35]  A. Clarke,et al.  Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine , 2003, American Sociological Review.

[36]  W. Gardner,et al.  Increasing identification of psychosocial problems: 1979-1996. , 2000, Pediatrics.

[37]  F. Dubois-Arber,et al.  Prevalence of Methylphenidate Prescription Among School-Aged Children in a Swiss Population: Increase in the Number of Prescriptions in the Swiss Canton of Vaud, From 2002 to 2005, and Changes in Patient Demographics , 2010, Journal of attention disorders.

[38]  B. Carleton,et al.  Trends in Psychostimulant and Antidepressant Use by Children in 2 Canadian Provinces , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[39]  J. Deligne,et al.  Prevalence and patterns of methylphenidate use in French children and adolescents , 2008, European Journal of Clinical Pharmacology.

[40]  G. Lehmkuhl,et al.  The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007. , 2010, Deutsches Arzteblatt international.

[41]  S. Macleod,et al.  Prescription medicine use by one million Canadian children , 2001 .

[42]  D. Sclar,et al.  Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99 , 2004, International clinical psychopharmacology.

[43]  S. Collishaw,et al.  Time trends in child and adolescent mental disorders , 2005, Current opinion in psychiatry.

[44]  P. Levine,et al.  The global market for ADHD medications. , 2007, Health affairs.

[45]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[46]  Patricia Goodson,et al.  Out of sight, not out of mind: strategies for handling missing data. , 2008, American journal of health behavior.

[47]  P. Williams,et al.  Attention Deficit/Hyperactivity Disorder in Preschool-Age Children: Issues and Concerns , 2011, Clinical pediatrics.

[48]  R. Mayes,et al.  DSM-III and the revolution in the classification of mental illness. , 2005, Journal of the history of the behavioral sciences.

[49]  S. Homan,et al.  Trends in the Prevalence of Chronic Medication Use in Children: 2002–2005 , 2008, Pediatrics.

[50]  Y. Hsia,et al.  Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK , 2009, European Journal of Epidemiology.

[51]  S. Faraone,et al.  Attention-Deficit Hyperactivity Disorder in Girls , 2006, CNS drugs.